icon-folder.gif   Conference Reports for NATAP  
 
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
 
 
 
Once Daily Sofosbuvir/Ledipasvir Fixed-Dose Combination With or Without Ribavirin: Data From the ELECTRON Trials
 
 
  Reported by Jules Levin
AASLD 2013 Nov 1-5 Washington DC
 
Edward J. Gane1, Catherine A. Stedman2, Robert H. Hyland3,
Xiao Ding3, Evguenia S. Svarovskaia3, Phil S. Pang3, William T. Symonds3 1Auckland Clinical Studies, Auckland, New Zealand; 2Christchurch Clinical Studies
Trust, Christchurch, New Zealand; 3Gilead Sciences, Inc, Foster City, CA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif